The impact of sex and cannabis on clinical features in first-admitted patients with psychosis.

There is a scarcity of studies investigating the effect of sex on the clinical and treatment characteristics of first-admitted patients with first-episode psychosis (FEP). The reasons for using cannabis and the effect of cannabis on clinical features have not received enough attention either. We aim therefore, to investigate sex differences in the reasons for cannabis use and to determine the effects of sex, cannabis use and their interaction on clinical variables at admission and at discharge from the inpatient unit. 204 first-admitted FEPs in two inpatient units in Spain were included. The reasons for using cannabis were determined using the Dixon questionnaire. Clinical variables were compared between sexes and between cannabis users and non-users. Cannabis use was more frequent in males, but females were more likely to smoke cannabis to "feel relaxed". There was a main effect of sex on positive psychotic symptoms and antipsychotics dose and an interaction effect of cannabis and sex on global functioning at discharge .Our findings show sex differences in the reasons for cannabis use and in some clinical and treatment characteristics among FEP patients. More studies focusing on gender perspectives are needed to develop more individualized treatments.

• Publication year

  2020

• Venue

  European Neuropsychopharmacology

• Publication date

  2020-04-11

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.euroneuro.2020.03.003PMID 32291209
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Substance abuse and gender differences in first episode psychosis: Impact on hospital readmissions.

  2018cited by this paper
• Sex Differences in Psychiatric Hospitalizations of Individuals With Psychotic Disorders

  2017cited by this paper
• Substance abuse and gender differences in first episode psychosis: Impact on hospital readmissions.

  2017cited by this paper
• Gender differences in one‐year outcomes of first‐presentation psychosis patients in inner‐city UK Early Intervention Services

  2017cited by this paper
• Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences

  2017cited by this paper
• The interaction of gender and cannabis in early phase psychosis.

  2017cited by this paper
• The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002-2014.

  2017cited by this paper
• Motivational changes of cannabis use prior to and during the course of schizophrenia

  2017cited by this paper
• How gender affects the pharmacotherapeutic approach to treating psychosis – a systematic review

  2017cited by this paper
• Gender differences in positive mental health among individuals with schizophrenia.

  2017cited by this paper
• Association of cannabis use with hospital admission and antipsychotic treatment failure in first episode psychosis: an observational study

  2016cited by this paper
• Marijuana use in the immediate 5-year premorbid period is associated with increased risk of onset of schizophrenia and related psychotic disorders.

  2016cited by this paper
• A comparison of the cumulative incidence and early risk factors for psychotic disorder in young adults in the Northern Finland Birth Cohorts 1966 and 1986

  2016cited by this paper
• Cannabis Use Is Associated With Increased Psychotic Symptoms and Poorer Psychosocial Functioning in First-Episode Psychosis: A Report From the UK National EDEN Study.

  2016cited by this paper
• Cannabis use is associated with 3years earlier onset of schizophrenia spectrum disorder in a naturalistic, multi-site sample (N=1119).

  2016cited by this paper
• Challenges in detecting and diagnosing substance use in women in the acute psychiatric department: a naturalistic cohort study

  2016cited by this paper
• Continued versus discontinued cannabis use in patients with psychosis: a systematic review and meta-analysis.

  2016cited by this paper
• How age and gender predict illness course in a first-episode nonaffective psychosis cohort.

  2016cited by this paper
• A Study of the Impact of Cannabis on Doses of Discharge Antipsychotic Medication in Individuals with Schizophrenia or Schizoaffective Disorder

  2016cited by this paper
• Issues related to sex differences in antipsychotic treatment

  2016cited by this paper
• Childhood trauma as a risk factor for psychosis: A sib-pair study.

  2015cited by this paper
• Substance Use in Patients With First-Episode Psychosis: Is Gender Relevant?

  2015cited by this paper
• Reasons for cannabis use in first-episode psychosis: Does strength of endorsement change over 12 months?

  2015cited by this paper
• Relationship between cannabis and psychosis: Reasons for use and associated clinical variables.

  2015cited by this paper
• Course of cannabis use and clinical outcome in patients with non-affective psychosis: a 3-year follow-up study

  2015cited by this paper
• Reasons and subjective effects of cannabis use among people with psychotic disorders: a systematic review.

  2014cited by this paper
• Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.

  2014cited by this paper
• Prognosis of schizophrenia in persons with and without a history of cannabis use

  2014cited by this paper
• One year follow-up of alcohol and illicit substance use in first-episode psychosis: does gender matter?

  2014cited by this paper
• Prevalence and correlates of alcohol and cannabis use disorders in the United States: results from the national longitudinal study of adolescent health.

  2014cited by this paper
• Clinical and cognitive predictors of vocational outcome in first-episode schizophrenia: a prospective 3 year follow-up study.

  2014cited by this paper
• Gender differences in first-episode psychosis at 5-year follow-up – two different courses of disease? Results from the OPUS study at 5-year follow-up

  2014cited by this paper
• Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study

  2013cited by this paper
• Reflections of young people who have had a first episode of psychosis: what attracted them to use alcohol and illicit drugs?

  2013cited by this paper
• ABC Schizophrenia study: an overview of results since 1996

  2013cited by this paper
• Cannabis use and cognitive functions in at-risk mental state and first episode psychosis

  2013cited by this paper
• Walking the fine line: Self-reported reasons for substance use in persons with severe mental illness

  2013cited by this paper
• Why do psychotic patients use cannabis? Case series.

  2012cited by this paper
• Gender Differences in Schizophrenia and First-Episode Psychosis: A Comprehensive Literature Review

  2012cited by this paper
• Effect of cannabis use on the course of schizophrenia in male patients: a prospective cohort study.

  2012cited by this paper
• Psychopharmacological comparison of schizophrenia spectrum disorder with and without cannabis dependency.

  2011cited by this paper
• Perceived reasons for and consequences of substance abuse among patients with psychosis.

  2010cited by this paper
• Gender differences in antipsychotic prescribing

  2010cited by this paper
• Illicit substance use and its correlates in first episode psychosis

  2010cited by this paper
• Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis.

  2010cited by this paper
• International consensus study of antipsychotic dosing.

  2010cited by this paper
• Cannabis use disorders in schizophrenia: effects on cognition and symptoms.

  2010cited by this paper
• Cannabis and First-Episode Psychosis: Different Long-term Outcomes Depending on Continued or Discontinued Use

  2009cited by this paper
• Impact of cannabis and other drugs on age at onset of psychosis.

  2008cited by this paper
• Gender differences in premorbid, entry, treatment, and outcome characteristics in a treated epidemiological sample of 661 patients with first episode psychosis.

  2008cited by this paper
• Reasons for using substances in adolescents with and without psychosis

  2008cited by this paper
• Gender differences in first episode psychosis

  2008cited by this paper
• Do Women Express and Experience Psychosis Differently from Men? Epidemiological Evidence from the Australian National Study of Low Prevalence (Psychotic) Disorders

  2008cited by this paper
• Gender differences in response to antipsychotic treatment in outpatients with schizophrenia.

  2007cited by this paper
• Naturalistic follow-up of co-morbid substance use in schizophrenia: the West London first-episode study

  2007cited by this paper
• Sex Selection Bias in Schizophrenia Antipsychotic Trials

  2006cited by this paper
• Substance-abusing schizophrenics: do they self-medicate?

  2004cited by this paper
• Reasons for cannabis use in men with and without psychosis.

  2004cited by this paper
• Gender differences in the prescribing of antipsychotic drugs.

  2004cited by this paper
• Gender differences and outcome in schizophrenia: a 2-year follow-up study in a large community sample

  2003cited by this paper
• Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study

  2002cited by this paper
• Sex differences in illness presentation, course, and level of functioning in substance-abusing schizophrenia patients.

  2000cited by this paper
• Gender aspects in schizophrenia: bridging the border between social and biological psychiatry

  2000cited by this paper
• Reasons for substance use in schizophrenia

  1997cited by this paper
• Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.

  1995cited by this paper
• Cannabis abuse and the course of recent-onset schizophrenic disorders.

  1994cited by this paper
• Past substance abuse and clinical course of schizophrenia.

  1992cited by this paper
• Drug abuse in schizophrenic patients: clinical correlates and reasons for use.

  1991cited by this paper
• The Positive and Negative Syndrome Scale--Spanish adaptation.

  1990cited by this paper

• Differential effect of cannabis use and antipsychotic medication on extracellular free-water in the brain of individuals with early psychosis and controls

  2025cites this paper
• Changes in cannabis use post decriminalisation in mental health care users in South Africa

  2025cites this paper
• Sex differences in the association of overweight with cognitive performance in individuals with first-episode psychosis

  2024cites this paper
• Scoping Review of Cannabis-Reduction Psychosocial Interventions and Reasons for Use among Young Adults with Psychosis

  2023influential citation
• Sex differences in functional outcome after hospitalisation: A systematic review and meta-analysis.

  2023cites this paper
• Exploration of cannabis use and polygenic risk scores on the psychotic symptom progression of a FEP cohort.

  2023cites this paper
• Sex differences in the clinical presentation of early psychosis in a primary care setting

  2023cites this paper
• Prevalence of cannabis use in people with psychosis in KwaZulu-Natal, South Africa

  2022cites this paper
• Impact of cannabis use and its cessation on the dosage and the efficacy of antipsychotic drugs in in- and outpatients with schizophrenia taking medication: A systematic review and meta-analysis.

  2022cites this paper
• Substance use Specificities in Women with Psychosis: A Critical Review

  2022cites this paper
• Incidence rate and distinctive characteristics of first episode psychosis during the COVID-19 pandemic: a multicenter observational study

  2022cites this paper
• Gender Differences in Dual Diagnoses Associated with Cannabis Use: A Review

  2022influential citation
• Cognitive Behavioral Therapy Program for Cannabis Use Cessation in First-Episode Psychosis Patients: A 1-Year Randomized Controlled Trial

  2022cites this paper
• Sex and gender differences in symptoms of early psychosis: a systematic review and meta-analysis

  2022cites this paper
• Comparative harms assessments for cannabis, alcohol, and tobacco: Risk for psychosis, cognitive impairment, and traffic accident

  2022cites this paper
• Cannabis use and psychosis susceptibility: A call to action.

  2021cites this paper
• Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study.

  2021cites this paper
• Cannabis research: Risks of recreational use and potential medical applications

  2020cites this paper
• The influence of sex and gender factors on the modulation of vulnerability to addictions: A narrative review

  year unknowncites this paper